3rd Quarter - Report
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 9260 - LHHS Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADISON SMITH | — |
Health Issues HCR
Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADISON SMITH | — |
Science/Technology SCI
National Security Commission on emerging biotechnology policy proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADISON SMITH | — |
Trade (domestic/foreign) TRD
Issues related to Section 232
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADISON SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.